Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News release more disappointing results

<< Previous

Bullboard Posts

Next >>

Comment by Kpain9999on Nov 28, 2024 7:17am

109 Views

Post# 36335164

RE:RE:News release more disappointing results

It is sad that conditions that might respond better and would be easier to treat don't seem to be getting any attention....eg. HSV (and other viruses) especially when TLD 1433 can do its thing even via metformin and/or xray. Huge market with life changing potential. Re Bladder cancer theoretically eventually why couldn't there be repetetive treatments until the cancer resolves? This would be easier with cancers where one wouldn't have to do bladder instillations and activation. All kinds of potential it appears but sure is taking a while.

<< Previous

Bullboard Posts

Next >>

Coppernico in Peru: Inaugural drilling on a promising opportunity